Assessment of stimulant use and cardiovascular event risks among older adults
Tadrous M, Shakeri A, Chu C, Watt J, Mamdani MM, Juurlink DN, Gomes T. JAMA Netw Open. 2021; 4(10):e2130795. Epub 2021 Oct 25.
Publications
Greater than the sum: applying daily-dose equivalents to antipsychotic prescription claims to study real-world effects
Hayes KN, Gomes T, Tadrous M. Front Pharmacol. 2021; 12:709349. Epub 2021 Aug 6.
Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada
Martins D, Khuu W, Tadrous M, Greaves S, Sproule B, Bozinoff N, Juurlink DN, Mamdani MM, Paterson JM, Gomes T. Pain. 2022; 163(1):e129-36. Epub 2021 Jul 28.
Risk of serious medical events in patients with depression treated with electroconvulsive therapy: a propensity score-matched, retrospective cohort study
Kaster TS, Vigod SN, Gomes T, Sutradhar R, Wijeysundera DN, Blumberger DM. Lancet Psychiatry. 2021; 8(8):686-95. Epub 2021 Jul 12.
Trends and outcomes of serious complications associated with non-fatal opioid overdoses in Ontario, Canada
Kitchen SA, McCormack D, Werb D, Caudarella A, Martins D, Matheson FI, Gomes T. Drug Alcohol Depend. 2021; 225:108830. Epub 2021 Jun 24.
Inequities in access to primary care among opioid recipients in Ontario, Canada: a population-based cohort study
Gomes T, Campbell TJ, Martins D, Paterson JM, Robertson L, Juurlink DN, Mamdani M, Glazier RH. PLoS Med. 2021; 8(6): e1003631. Epub 2021 Jun 1.
Trends in postpartum opioid prescribing: a time series analysis
Zipursky JS, Pang A, Paterson J, Austin PC, Mamdani M, Gomes T, Ray JG, Juurlink DN. Clin Pharmacol Ther. 2021; 110(4):1004-10. Epub 2021 May 25.
Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial
Persaud N, Bedard M, Boozary A, Glazier RH, Gomes T, Hwang SW, Juni P, Law MR, Mamdani M, Manns B, Martin D, Morgan SG, Oh P, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A; Carefully seLected and Easily Accessible at No Charge Medications (CLEAN Meds) study team. PLoS Med. 2021; 18(5):e1003590. Epub 2021 May 21.
Impact of COVID-19 on prescribing trends of direct-acting antivirals for the treatment of hepatitis C in Ontario, Canada
Konstantelos N, Shakeri A, McCormack D, Feld JJ, Gomes T, Tadrous M. Am J Gastroenterol. 2021; 116(8):1738-40. Epub 2021 Apr 28.
Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study
Holbrook A, Benipal H, Paterson JM, Martins D, Greaves S, Lee M, Gomes T. CMAJ Open. 2021; 9(2):E364-75. Epub 2021 Apr 16.